Life/Health Insurance Stocks Experience a 2.99% Decline!
📉 Intro Description:
Life/Health insurance stocks are under pressure, seeing a loss of nearly 3%. With a "Strong Sell" rating backing most stocks in this category, traders need to exercise caution. A deeper dive will provide a better understanding of individual stocks and market movements.
📉 Life/Health Insurance Sector Faces Challenges with a -2.99% Loss, but AI Robots Can Help You Minimize Losses! 🤖📈
With AI-powered tools at your disposal, you can better navigate the Life/Health Insurance sector, mitigate potential losses, and make data-driven choices.
📊 "Swing Trader, Long Only: Valuation & Efficiency Model (TA&FA)" offers a strategic approach to valuation and efficiency within the sector. By leveraging AI insights, you can make more informed decisions and optimize your trading within this space.
🌟 "Swing Trader, Long Only: Valuation & Seasonality Model (TA&FA)" takes into account seasonality trends, allowing you to adjust your strategy based on historical patterns.
Stay ahead of market fluctuations with AI precision! 💼📊🌟
Tickers of this Group:
$CNO $UNM $AFL $AEL $MFC $PRU $MET $GNW $PUK $LNC $PRI $NWLI $BHF $FG $GL $ABL $BHFAN $BHFAO $BHFAP $JXN $BHFAM
🏢 Industry Description:
Life insurance companies offer policies that pay beneficiaries a lump sum upon the insured's death. These policies can be term or whole life. Life insurance firms might also provide long-term disability policies to replace income if the insured becomes sick or disabled. Health insurance helps cover medical expenses. Major players include Anthem, Inc., MetLife, Inc., and Aflac Incorporated.
📊 Market Cap:
The average market cap across this industry is 14.1B. Topping the list is $MET with a valuation of 46.4B, while $BHFAN stands at the lower end with zero.
📈 High and Low Price Notable News:
Price growth in the last week was -3.31% on average across all stocks in the sector. Monthly and quarterly price growth rates stand at -5.83% and 10.96% respectively. $ABL stands out with a positive growth of 2.36%, while $BHFAM declined the most, dropping 7.86%.
🔊 Volume:
Weekly volume growth averaged 8.92% across all stocks. Monthly and quarterly volume growth rates for the same set of stocks were 65.33% and 21.24% respectively.
📚 Fundamental Analysis Ratings:
🌐 Notable Companies:
Prominent companies in this industry include MetLife ($MET), Prudential Financial ($PRU), Lincoln National Corp ($LNC), and Genworth Financial ($GNW).
📜 Ticker Analysis:
$CNO:
MACD Analysis: Turned negative on October 03, 2023, indicating a potential decline with a probability of 71%.
Stock Forecast: Price of $23.05 is trading between resistance of $24.64 and support of $21.07. Price fell by 2% in the last month.
$UNM:
Moving Average Analysis: Fell below its 50-day Moving Average on October 03, 2023. A downward trend is probable with 76% chances.
Stock Forecast: Current price of $48.15 is trading between support of $48.26 and resistance of $40.99. Price declined by 2% over the last month.
$AFL:
Momentum Indicator Analysis: Moved below the 0 level on October 02, 2023, signaling a probable shift to a new downward trend. The historical trend shows a 56% chance of a further decline.
Stock Forecast: The current price of $76.07 has surpassed the resistance line at $64.00 and is trading between support at $97.03 and resistance at $64.00. Over the last month, the price showed a +1% Uptrend, but declined by 1% in the past week.
$AEL:
Momentum Indicator Analysis: The indicator moved below the 0 level on September 25, 2023. This suggests a potential downward trend. Historically, in similar scenarios, the stock declined 68% of the time.
Stock Forecast: Currently trading at $53.40, the stock has crossed its resistance of $50.98. It's now positioned between the $58.39 resistance and $50.98 resistance lines. The past month witnessed a slight downtrend of -0.95%, with the stock falling -0.90% in the last week.
$MFC:
Moving Average Analysis: The 50-day Moving Average for MFC crossed below its 200-day moving average on September 29, 2023. This is typically seen as a long-term bearish signal.
Stock Forecast: The current stock price of $17.68 is trading between support at $17.93 and resistance at $14.80. In the last month, there has been a -5% downtrend, and in the past week, the stock has declined by 5%.
$PRU:
Trend Analysis: PRU is in a 3.74% downward trend, witnessing decline for three consecutive days as of October 03, 2023. Historically, 65% of similar situations led to further declines in the following month.
Stock Forecast: PRU, priced at $91.17, has crossed its support line at $88.99. It currently trades between the resistance at $123.23 and support at $88.99. Over the last month, a -4% downtrend was observed, with a 4% decline in the last week.
$MET:
Moving Average Analysis: The stock moved below its 50-day Moving Average on September 27, 2023, suggesting a shift from an upward trend to a downward one. There's a 59% likelihood of the stock continuing this downward trend based on past data.
Stock Forecast: With a current price of $59.99, it is below the lowest support line of $65.15 defined by A.I. The past month saw a -5% decline, with a weekly decline of -4%.
$GNW:
Moving Average Analysis: As of October 03, 2023, GNW moved below its 50-day Moving Average, indicating a potential change from an upward trend to a downward one. Historically, the stock has decreased 85% of the time in such scenarios.
Stock Forecast: Trading at $5.88, the stock has crossed its support at $5.27. It's now between the support of $6.88 and $5.27. The past month witnessed a -2% decline, with a similar -2% decrease in the past week.
On December 23, 2024, the Stochastic Oscillator for CNO moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 55 instances where the indicator left the oversold zone. In of the 55 cases the stock moved higher in the following days. This puts the odds of a move higher at over .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CNO's RSI Oscillator exited the oversold zone, of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CNO advanced for three days, in of 310 cases, the price rose further within the following month. The odds of a continued upward trend are .
CNO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 301 cases where CNO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Momentum Indicator moved below the 0 level on December 06, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on CNO as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CNO turned negative on November 29, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .
CNO moved below its 50-day moving average on December 18, 2024 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CNO crossed bearishly below the 50-day moving average on December 23, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CNO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.334) is normal, around the industry mean (1.496). P/E Ratio (11.333) is within average values for comparable stocks, (39.438). CNO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (0.675). Dividend Yield (0.022) settles around the average of (0.140) among similar stocks. P/S Ratio (0.755) is also within normal values, averaging (2.172).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of health and life insurance services
Industry LifeHealthInsurance